Bank Of America Corp Bausch Health Companies Inc. Call Options Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $396,500 - $676,650	65,000 Added 32.5%	265,000 $1.85 Million
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $8.93 Million - $12.2 Million	-1,149,900 Reduced 85.18%	200,000 $2.12 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $6.2 Million - $7.82 Million	949,900 Added 237.48%	1,349,900 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $1.72 Million - $2.64 Million	300,000 Added 300.0%	400,000 $3.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $458,000 - $921,000	100,000 New	100,000 $689,000

266

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.44B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.